National Abortion Federation
13
10. Blum J, Raghavan S, Dabash R, Ngoc NT, Chelli H, Hajri S, et al. Comparison of misoprostol-only and
combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam.
Int J Gynaecol Obstet. 2012;118(2):166-71.
11. World Health Organization. Safe abortion: technical and policy guidance for health systems. 2nd ed.
Geneva2012.
12. Lohr PA, Reeves MF, Hayes JL, Harwood B, Creinin MD. Oral mifepristone and buccal misoprostol
administered simultaneously for abortion through 63 days gestation [abstract]. Contraception. 2006;74(2):181.
13. Creinin MD, Fox MC, Teal S, Chen A, Schaff EA, Meyn LA, et al. A randomized comparison of misoprostol
6 to 8 hours versus 24 hours after mifepristone for abortion. Obstet Gynecol. 2004;103(5 Pt 1):851-9.
14. Schaff EA, Fielding SL, Westhoff C, Ellertson C, Eisinger SH, Stadalius LS, et al. Vaginal misoprostol
administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial.[erratum appears
in JAMA 2000 Nov 22-29;284(20):2597]. JAMA. 2000;284(15):1948-53.
15. Boersma AA, Meyboom-de Jong B, Kleiverda G. Mifepristone followed by home administration of buccal
misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Curaçao. The European
Journal of Contraception and Reproductive Health Care. 2011;16(2):61-6.
16. Gouk EV, Lincoln K, Khair A, Haslock J, Knight J, Cruickshank DJ. Medical termination of pregnancy at 63
to 83 days gestation. Br J Obstet Gynaecol. 1999;106(6):535-9.
17. Winikoff B, Dzuba IG, Creinin MD, Crowden WA, Goldberg AB, Gonzales J, et al. Two distinct oral routes
of misoprostol in mifepristone medical abortion: a randomized controlled trial. Obstet Gynecol.
2008;112(6):1303-10.
18. von Hertzen H, Piaggio G, Huong NT, Arustamyan K, Cabezas E, Gomez M, et al. Efficacy of two intervals
and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled
equivalence trial. Lancet. 2007;369(9577):1938-46.
19. Kulier R, Kapp N, Gulmezoglu AM, Hofmeyr GJ, Cheng L, Campana A. Medical methods for first trimester
abortion. Cochrane Database Syst Rev. 2011(11):CD002855.
20. Singh K, Fong YF, Dong F. A viable alternative to surgical vacuum aspiration: repeated doses of intravaginal
misoprostol over 9 hours for medical termination of pregnancies up to eight weeks. BJOG. 2003;110(2):175-80.
21. Salakos N, Kountouris A, Botsis D, Rizos D, Gregoriou O, Detsis G, et al. First-trimester pregnancy
termination with 800 microg of vaginal misoprostol every 12 h. Eur J Contracept Reprod Health Care.
2005;10(4):249-54.
22. Rodriguez MI, Seuc A, Kapp N, von Hertzen H, Huong NTM, Wojdyla D, et al. Acceptability of
misoprostol-only medical termination of pregnancy compared with vacuum aspiration: an international,
multicentre trial. BJOG: an International Journal of Obstetrics & Gynaecology. 2012;119(7):817-23.
23. Aldrich T, Winikoff B. Does methotrexate confer a significant advantage over misoprostol alone for early
medical abortion? A retrospective analysis of 8678 abortions. Bjog. 2007;114(5):555-62.
24. Carbonell Esteve JL, Varela L, Velazco A, Tanda R, Sanchez C. 25 mg or 50 mg of oral methotrexate followed
by vaginal misoprostol 7 days after for early abortion: a randomized trial. Gynecol Obstet Invest.
1999;47(3):182-7.